Clinical Trials in China / NCT06604169
Active, not recruiting
Observational
An Observational Study of Subcutaneous Implantable Cardioverter Defibrillator in Patients with Hypertrophic Cardiomyopathy At High Risk of Sudden Cardiac Death
NCT06604169 · tracked via the Priya Life Science China tracker
Condition(s) studied
HCM - Hypertrophic CardiomyopathyS-ICD System (implantable Defibrillator)
Study summary
1. To observe the failure rate of S-ICD screening in HCM patients at high risk of SCD.
2. To observe the incidence of IAS in HCM patients with S-ICD implantation and explore the related factors of IAS.
Eligibility
Inclusion Criteria:
* HCM patients assessed as meeting the ICD implantation indication
Exclusion Criteria:
* Combined with bradycardia with pacing indications;
* Frequent monomorphic ventricular tachycardia require ATP therapy;
* With indications of CRT;
* Combined with other diseases, life expectancy is less than 1 year.
Primary outcome measure(s)
- the failure rate of S-ICD screening — 3 months
S-ICD screening failed - The inappropriate shock event — 3 months
The incidence of inappropriate shock event
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Fuwai hospital | Beijing | China |
More China National Center for Cardiovascular Diseases trials in China
Other trials for the same condition
Automated Reports Generation of Cardiovascular Magnetic Resonance Imaging
Active, not recruiting
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06604169 on ClinicalTrials.gov ↗ ← All trials in China